Press Releases
Aptar Pharma and Propeller Health Partner to Develop Digital...
Aptar Pharma, a leading provider of innovative drug delivery systems, and Propeller Health, a leading digital therapeutics company, announced plans to collaborate on the launch...
Press Releases
More Global Recognition for CRF Health’s eSource Solutionswith European...
CRF Health, a leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, announced that the company has been recognized...
Press Releases
CPhI report predicts new finished product manufacturing hub in...
A new report by CPhI forecasts sizable changes ahead for the pharma markets in the Middle East and Africa over the next few years. ...
Press Releases
Pfizer’s Biosimilar RETACRIT® (epoetin alfa-epbx) Approved by U.S. FDA
Pfizer Inc. announced the United States FDA approved RETACRIT® (epoetin alfa-epbx), a biosimilar to Epogen® and Procrit® (epoetin alfa)1, for all indications of the reference...
Press Releases
Recipharm invests in Brexit preparations
Recipharm, the contract development and manufacturing organisation (CDMO), has established a dedicated taskforce to manage the potential impact of Brexit on its organisation. ...
Press Releases
Aptar Pharma to Unveil Inhalation Drug Delivery Solutions at...
Aptar Pharma, a leading drug delivery systems provider, is pleased to be exhibiting once again at CPhI China 2018, taking place from June 20-22 at...
Press Releases
Lonza Further Strengthens Hepatocytes Portfolio with Addition of Hepatic...
Lonza announced the addition of hepatic stellate cells, Kupffer cells and liver-derived endothelial cells to its extensive hepatocytes portfolio. These hepatic non-parenchymal...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.